Ausgabe 3/2005
Inhalt (12 Artikel)
Chemotherapy-induced peripheral neuropathy: An increasing concern for oncologists
Maurie Markman
First-line therapy for advanced colorectal cancer
Aimery de Gramont, Christophe Tournigand, Christophe Louvet, Frédérique Maindrault-Goebel, Thierry André
Chemotherapy for advanced pancreatic cancer: Past, present, and future
Gregory Friberg, Hedy Lee Kindler
Chemoradiotherapy for gastrointestinal cancers
Tyvin A. Rich, Christopher Crane, Joshua D. Lawson, Jerome Landry
Docetaxel-based chemotherapy trials in androgen-independent prostate cancer: First demonstration of a survival benefit
Daniel P. Petrylak
Adjuvant chemotherapy for transitional cell carcinoma of the bladder: Paradigms for the design of clinical trials
Michelle Boyar, Daniel P. Petrylak
Angiogenesis and prostate cancer: Important laboratory and clinical findings
Michael C. Cox, Matthew Permenter, William D. Figg
Chemotherapy for advanced prostate cancer: Results of new clinical trials and future studies
Andrew J. Armstrong, Michael A. Carducci